Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2840195 | Clínica e Investigación en Arteriosclerosis | 2006 | 4 Pages |
Abstract
The addition of ezetimibe in patients treated with statins produces an additional 25% reduction in total cholesterol, a 36% reduction in low-density lipoprotein cholesterol (LDL-C), and a 24% reduction in triglycerides. This decrease enables 40% of the patients who do not achieve their LDL-C goals according to their coronary risk to achieve them after ezetimibe therapy. Combined treatment with ezetimibe and statins improves the control of hyperlipidemias.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Physiology
Authors
J.M. Pascual, E. Rodilla, C. Sánchez,